Switch to:
More From Other Websites
Kite Pharma Reports Favorable Data from Lymphoma Study Sep 27 2016
Kite Pharma Soars As Cancer Drug Trial Supportive Of FDA Approval Sep 27 2016
ETF’s with exposure to Novartis AG : September 26, 2016 Sep 26 2016
The Internet of Medical Things: 6 Stocks in Focus Sep 26 2016
Novartis Ilaris Approved for Extended Use in Periodic Fever Sep 26 2016
3:21 am Novartis reports positive top-line results from ASCEND-4; moving forward with global... Sep 25 2016
Novartis receives three new FDA approvals for the expanded use of Ilaris for patients with rare... Sep 23 2016
Novartis receives three new FDA approvals for the expanded use of Ilaris treating rare Periodic... Sep 23 2016
Novartis (NVS) Zykadia Positive in Phase III ASCEND-4 Study Sep 23 2016
UPDATE 1-Novartis's Zykadia gets positive results, faces Roche pressure Sep 23 2016
Novartis announces positive top-line results from ASCEND-4, a Phase III trial of Zykadia® in... Sep 23 2016
Gilead, Allergan Seen Trailing Intercept In Ongoing NASH Battle Sep 22 2016
A Double Dose of Trouble at Novartis Sep 22 2016
Does Novartis AG (NVS) Have The Solution For Malaria? Sep 22 2016
Novel Novartis malaria compound shows potential to be effective against infections resistant to all... Sep 21 2016
Breaking the mould: GSK picks Big Pharma's first female CEO Sep 20 2016
Breaking the mould: GSK picks Big Pharma's first female CEO Sep 20 2016
Breaking the mould: GSK picks Big Pharma's first female CEO Sep 20 2016
Breaking the mould: GSK picks Big Pharma's first female CEO Sep 20 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK